#ESMO26 is nearly here, and I'm hyped. Ten of 12 Presidential abstracts are expected to show primary endpoints met. Seven have declared a survival win, including the VOLGA trial now under priority review. #oncology #onctwitter #MedEd https://t.co/uznyLGzNK5